For citations:
Glibka A.A., Mel`nichenko G.A., Mikhina M.S., Mazurina N.V., Kharkevich G.Yu. Development of destructive thyroiditis and diabetes mellitus after three injections of pembrolizumab for skin melanoma. Problems of Endocrinology. 2021;67(2):20-27. https://doi.org/10.14341/probl12698

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).